Trial Profile
A Study to Evaluate the Optimal Dose of Intravenous Dexmedetomidine for Proper Sedation with Minimal Recovery Time in Spinal Anesthesia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions
- 05 Dec 2015 New trial record